Thursday, 02 April 2020

Australia News

  • No of AMD patients to reach 1.7 mn by 2030 in Aus

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 06 May, 2013

    Singapore: The number of Australians with age-related macular degeneration (AMD) is expected to grow to over 1.7 million by 2030, yet many patients do not currently receive timely care. Th...Read more

  • Bionomics cancer trial shows +ve results

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

    Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its cancer drug candidate BNC105 in women with ovarian cancer. After com...Read more

  • Melanoma study reaches efficacy milestone

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2012

    Singapore: Australia-based Viralytics in its ongoing US-based phase II melanoma trial of its virotherapy candidate Cavatak achieved an interim efficacy milestone of three Objective Respons...Read more

  • NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, anti-infective products for the treatment and prevention of topical infe...Read more

  • Medigene, SynCore expand deal for Veregen

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 20 Mar, 2013

    Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expanded the existing exclusive licensing and supply contract into new re...Read more

  • Kane Biotech issued patent in Australia for Aledex

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

    Singapore: Canada-based Kane Biotech, which is engaged in the development and commercialization of products that prevent and remove microbial biofilms, has been granted a patent by the Aust...Read more

  • Aus, NZ progress on joint regulatory agency

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic Products Agency (ANZTPA) implementation ministerial council in a con...Read more

  • Aerocrine receives Australian TGA approval

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 May, 2012

    Singapore: Aerocrine received marketing approval for its airway inflammation monitor, NIOX MINO and NIOX MINO Test Kit, in the Australian market. The decision to grant the marketing approva...Read more

  • Lipitor leads in Australia

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China. According to BioSpectrum Top20 survey for the Asia Pa...Read more

  • Innova, TGR to co-market ELISA technology

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jan, 2014

    Singapore: Australia-based, TGR BioSciences, a life sciences company focused on the development of rapid, high sensitivity ELISA systems using their CaptSure technology, and UK-based Innova...Read more

  • Alchemia appoints new chairman

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

    Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-executive Chairman of the Board of Directors, effective as of 1 March 20...Read more

  • Bionomics, Merck Serono end agreement

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended their agreement to jointly develop new treatments for MS and other aut...Read more

  • AstraZeneca, Alchemia sign $240 mn drug deal

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

    Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary Diversity Scanning Array (DSA) and associated...Read more

  • Victoria court approves Biota's merger with Nabi Biopharma

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

    Singapore: The Supreme Court of Victoria has approved the scheme of arrangement between Biota Holdings and the holders of its ordinary shares that will result in the merger of Biota and Nab...Read more

  • Eisai gets approval for Halaven in Australia

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: Eisai Australia, a subsidiary of the Japanese firm Eisai, has received approval from the Australian Department of Health and Aging to market its anticancer agent Halaven (eribul...Read more

  • GI Dynamics starts US trial of EndoBarrier

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

    Singapore: GI Dynamics has initiated its US multicenter pivotal clinical trial of EndoBarrier, the Endo trial, for the treatment of patients, who have uncontrolled type 2 diabetes and are ...Read more

  • Pharmaxis for Prix Galien UK award

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2014

    Singapore: Six companies have been short listed for this year's internationally recognised Prix Galien award UK Orphan Drug Award, that covers innovations in pharmaceutical R&D. Austral...Read more

  • Genome of extinct frog revived for fresh egg

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: The genome of an extinct Australian frog has been revived and reactivated by a team of scientists using sophisticated cloning technology to implant a "dead" cell nucleus into a f...Read more